Advertisement

How to Induce Arrhythmias with Noradrenaline

  • Ispas Alexandru
Chapter

Abstract

Noradrenaline is a precursor of adrenaline, secreted by the adrenal part of the medulla, and like dopamine is a neurotransmitter found in the brain and other parts of the body. Noradrenaline is important in the response and recovery after injury or serious illness. Furthermore, significant plasma levels are seen in patients with different types of shock, severe hypoxemia, or cardiac failure. Cellular response to noradrenaline is mediated by receptors that are located on target cells. It has the potential of facilitating cardiac arrhythmias by β1 receptor stimulation, alpha-1 receptor stimulation, or increase in myocardial oxygen consumption. When noradrenaline is injected intravenously, a rise in the blood pressure occurs rapidly. The effect is of short duration. After 1–2 min of discontinuation of infusion, the pressor response disappears. Noradrenaline is a sympathicomimetic with a double effect on the α and β postsynaptic receptors. Furthermore, sympathetic stimulation by noradrenaline leads to adrenaline secretion from the medulosuprarenal gland, with further effect on the α and β receptors. On the other hand, the effects of noradrenaline are different of those of adrenaline, even though they both act on the α and β receptors.

References

  1. 1.
    von Euler US, Harnberg U. L-noradrenaline in the suprarenal medulla. Nature. 1949;163:642–63.CrossRefGoogle Scholar
  2. 2.
    Weiss R, Knight BP, Bahu M, Zivin A, Souza J, Goyal R, Daoud E, Man C, Strickberger A, Halter JB, Morady F. Cardiac electrophysiologic effects of norepinephrine in human beings. Am Heart J. 1998;135:945–51.CrossRefGoogle Scholar
  3. 3.
    Brown RA, Carpentier RG. Alpha-adrenoreceptor- mediated effects of norepinephrine on the guinea pig sinus node. J Electrocardiol. 1988;21:213–7.CrossRefGoogle Scholar
  4. 4.
    Gilbert JL, Lange G, Polevoy I, Brooks CM. Effects of vasoconstrictor agents on cardiac irritability. J Pharmacol Exp Ther. 1958;123:9–15.PubMedGoogle Scholar
  5. 5.
    Hauswirth O, Noble D, Tsien RW. Adrenaline: mechanism of action on the pacemaker potential in cardiac Purkinje fibers. Science. 1968;162:916–7.CrossRefGoogle Scholar
  6. 6.
    Brown RA, Carpentier RG. Alpha-adrenoceptor-mediated effects of norepinephrine on the guinea pig sinus node. J Electrocardiol. 1988;21:213–7.CrossRefGoogle Scholar
  7. 7.
    Fedida D, Shimoni Y, Giles WR. A novel effect of norepinephrine on cardiac cells is mediated by alpha adrenoceptors. Am J Physiol. 1989;256:H15lXl-4.Google Scholar
  8. 8.
    Lukas A, Ferrier GR. Arrhythmic effects of norepinephrine in a model of cardiac ischemia and reperfusion. Can J Physiol Pharmacol. 1989;67:765–71.CrossRefGoogle Scholar
  9. 9.
    Friedrichs GS, Merrill GF. Adenosine desaminase and adenosine attenuate ventricular arrhythmias caused by norepinephrine. Am J Phys. 1991;260:H979–84.Google Scholar
  10. 10.
    Wax SD, Webb WR, Ecker RR, Sugg WL. Evaluation of antifibrillatory agents and catecholamines by a physiologic method. Surg Forum. 1968;19:J49–51.Google Scholar
  11. 11.
    Papp JG, Szekeres L. Analysis of the mechanism of adrenergic actions on ventricular vulnerability. Eur J Pharmacol. 1968;3:15–26.CrossRefGoogle Scholar
  12. 12.
    Sharma AD, Waxman MB, Huerta F. Effect of adrenergic stimulation and blockade on ventricular defibrillation in the rat. J Pharmacol Exp Ther. 1983;227:716–22.PubMedGoogle Scholar
  13. 13.
    Goldenberg M, Pines KL, Baldwin EF, Green DG, Roh CE. The hemodynamic response of man to norepinephrine and epinephrine and relation to the problem of hypertension. Am J Med. 1948;5:792–806.CrossRefGoogle Scholar
  14. 14.
    Desjars P, Pinaud M, Potel G, Tasseau F, Touze MD. A reappraisal of norepinephrine therapy in human septic shock. Crit Care Med. 1987;15:134–7.CrossRefGoogle Scholar
  15. 15.
    De Baker D, Biston P, Devriendt J, et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med. 2010;362:779–89.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Ispas Alexandru
    • 1
  1. 1.Cardiology DepartmentCentre Hospitalier Annecy-GenevoisAnnecyFrance

Personalised recommendations